Dwarfism

Search with Google Search with Bing
Information
Disease name
Dwarfism
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03255694 Active, not recruiting Phase 2 A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature May 12, 2017 June 2030
NCT00001343 Completed Phase 2 The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome December 11, 1992 October 10, 2007
NCT00001536 Completed Issues Surrounding Prenatal Genetic Testing for Achondroplasia August 1996 July 2000
NCT00001754 Completed Study of Skeletal Disorders and Short Stature June 1998 May 2001
NCT00234533 Completed Phase 3 Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq June 2004 July 2008
NCT01157793 Completed Phase 4 A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood September 2003 February 2005
NCT00001190 Completed Phase 2 Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature November 1983 October 2001
NCT03221088 Unknown status Phase 2 A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature June 2015
NCT03535415 Unknown status Phase 3 A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation June 25, 2018 September 2021
NCT03635580 Unknown status Phase 3 Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS June 11, 2018 October 30, 2021
MeSH unique ID (MeSH (Medical Subject Headings))
D004392